Cg Oncology Inc [CGON] stock is trading at $26.91, up 3.34%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CGON shares have gain 2.24% over the last week, with a monthly amount glided 3.50%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, JP Morgan started tracking the stock with Overweight rating on May 02, 2025, and set its price target to $41. On April 16, 2025, Scotiabank initiated with a Sector Perform rating and assigned a price target of $23 on the stock. TD Cowen started tracking the stock assigning a Buy rating. UBS initiated its recommendation with a Buy and recommended $60 as its price target on October 24, 2024. RBC Capital Mkts started tracking with a Outperform rating for this stock on September 23, 2024, and assigned it a price target of $66. In a note dated August 28, 2024, ROTH MKM initiated an Buy rating and provided a target price of $65 on this stock.
Cg Oncology Inc [CGON] stock has fluctuated between $14.80 and $40.47 over the past year. Currently, Wall Street analysts expect the stock to reach $55 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $26.91 at the most recent close of the market. An investor can expect a potential return of 104.38% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Cg Oncology Inc [NASDAQ:CGON] reported sales of 0.66M for the trailing twelve months, which represents a drop of -90.17%. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -203.02%, Pretax Profit Margin comes in at -159.45%, and Net Profit Margin reading is -159.45%. To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.17 and Total Capital is -0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 25.99 points at the first support level, and at 25.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 28.17, and for the 2nd resistance point, it is at 29.42.
Ratios To Look Out For
For context, Cg Oncology Inc’s Current Ratio is 30.97. Also, the Quick Ratio is 30.97, while the Cash Ratio stands at 1.83. Considering the valuation of this stock, the price to sales ratio is 3107.91, the price to book ratio is 2.91.
Transactions by insiders
Recent insider trading involved POST LEONARD E, Director, that happened on Jul 17 ’25 when 2000.0 shares were sold. Director, LEONARD E POST completed a deal on Jul 17 ’25 to buy 2000.0 shares. Meanwhile, Director POST LEONARD E sold 1000.0 shares on May 21 ’25.
